Drug Discovery

Beckman Coulter Unveils Advanced Cydem VT Automated Screening System
Research & Development Beckman Coulter Unveils Advanced Cydem VT Automated Screening System

Beckman Coulter Life Sciences, a subsidiary of Danaher Corporation, has announced the launch of the Cydem VT Automated Clone Screening System, an innovative platform designed to transform the world of drug discovery through advanced laboratory automation and innovation. This groundbreaking

Innovative Technologies Revolutionize Platelet Function Assessments
Research & Development Innovative Technologies Revolutionize Platelet Function Assessments

Platelets play an essential role in human physiology, particularly during the clotting process in response to injury. Despite their importance, the comprehension and measurement of platelet functionality have consistently posed challenges for scientists and clinicians. This issue has become even

Can DP2A Revolutionize Hair Loss Treatment for Androgenetic Alopecia?
Research & Development Can DP2A Revolutionize Hair Loss Treatment for Androgenetic Alopecia?

Androgenetic alopecia (AGA), a condition affecting millions of men globally, is characterized by the progressive miniaturization of hair follicles, leading to significant hair loss. This condition is primarily caused by dihydrotestosterone (DHT), a testosterone derivative, as well as elevated

Can a Nasal Spray Halt Alzheimer's Progression by Targeting Enzymes?
Research & Development Can a Nasal Spray Halt Alzheimer's Progression by Targeting Enzymes?

A promising new approach in battling Alzheimer's disease has emerged, involving an innovative nasal spray drug that targets a specific brain enzyme. Researchers at Università Cattolica and Fondazione Policlinico Universitario A. Gemelli IRCCS have discovered that inhibiting the enzyme

USC and Autobahn Labs Partner to Accelerate Early-Stage Drug Discovery
Research & Development USC and Autobahn Labs Partner to Accelerate Early-Stage Drug Discovery

The University of Southern California (USC) has entered into a groundbreaking partnership with Autobahn Labs to speed up early-stage drug discovery, marking a transformative step in translating academic research into effective treatments. This collaboration aims to leverage USC's vast

How Will AI Transform Drug Development by 2025?
Research & Development How Will AI Transform Drug Development by 2025?

The pharmaceutical industry stands on the precipice of a monumental shift, driven by the rapid progress in artificial intelligence (AI). By 2025, AI is expected to significantly transform drug development processes, making them more efficient, accurate, and personalized. This article delves into

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later